LARGE FAMILY FOR LARGE ACHIEVEMENTS
We develop modern prevention, diagnostics and therapy products for health preservation and improved quality of life.
Press centre
PRESS CENTAR / NEWS
Record semi-annual performance of Bosnalijek in 2022
In the first half of 2022, Bosnalijek, the largest pharmaceutical company in Bosnia and Herzegovina, made record profit before tax of BAM 20.7 million, an increase by BAM 18.9 million compared to the same period of the previous year. The profit is the result of the successfully implemented strategy and activities of the management and employees of Bosnalijek.
MORE
PRESS CENTAR / NEWS
Record semi-annual performance of Bosnalijek in 2022
In the first half of 2022, Bosnalijek, the largest pharmaceutical company in Bosnia and Herzegovina, made record profit before tax of BAM 20.7 million, an increase by BAM 18.9 million compared to the same period of the previous year. The profit is the result of the successfully implemented strategy and activities of the management and employees of Bosnalijek.
In detail
PRESS CENTRE / NEWS
Bosnalijek Opens New Facility for Manufacturing Liquid and Semisolid Pharmaceutical Forms
With investment valued at 50 million convertible marks (BAM), Bosnalijek will see fivefold increase in its production capacities. This modern production plant ensures the reputation of a manufacturer with the highest quality standards.
In detail
Useful Resources
novembar 26. 2022 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%